Palm Beach, Fla. - Low-pulse cyclosporin-A is a promising treatment for Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), Sabra Sullivan, M.D., chief of dermatology, University of Mississippi (Jackson) Medical Center, reported the annual meeting of the Noah Worcester Dermatological Society.
